Noopur Raje

5 ta ish

Harvard University

1. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

   Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25

   Maqola20217 iqtibos

   ABIABI:AkademIndex/2026.other.296878

2. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

   Noopur Raje, Jesús G. Berdeja, Yi Lin +20

   MaqolaOAOchiq kirish20195 iqtibos

   ABIABI:AkademIndex/2026.other.082848

3. Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by <i>Nanoparticle Albumin-Bound</i> –Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma

   Diana Cirstea, Teru Hideshima, Scott J. Rodig +15

   MaqolaOAOchiq kirish20102 iqtibos

   ABIABI:AkademIndex/2026.other.003075

4. How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma

   Adam D. Cohen, Noopur Raje, Jessica Fowler +3

   Sharh maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.296857

5. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

   Hervé Avet‐Loiseau, Faith E. Davies, Mehmet Samur +43

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.480252